PTCT logo

PTC Therapeutics, Inc. (PTCT) Cash From Operations

Annual CFO:

-$107.69M+$50.73M(+32.02%)
December 31, 2024

Summary

  • As of today, PTCT annual cash from operations is -$107.69 million, with the most recent change of +$50.73 million (+32.02%) on December 31, 2024.
  • During the last 3 years, PTCT annual cash from operations has risen by +$143.64 million (+57.15%).
  • PTCT annual cash from operations is now -970.14% below its all-time high of -$10.06 million, reached on December 31, 2017.

Performance

PTCT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTCTcash flow metrics

Quarterly CFO:

-$66.30M-$7.97M(-13.66%)
September 30, 2025

Summary

  • As of today, PTCT quarterly cash from operations is -$66.30 million, with the most recent change of -$7.97 million (-13.66%) on September 30, 2025.
  • Over the past year, PTCT quarterly cash from operations has increased by +$10.69 million (+13.89%).
  • PTCT quarterly cash from operations is now -107.62% below its all-time high of $870.10 million, reached on March 31, 2025.

Performance

PTCT Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTCTcash flow metrics

TTM CFO:

$715.47M+$10.69M(+1.52%)
September 30, 2025

Summary

  • As of today, PTCT TTM cash from operations is $715.47 million, with the most recent change of +$10.69 million (+1.52%) on September 30, 2025.
  • Over the past year, PTCT TTM cash from operations has increased by +$893.44 million (+502.01%).
  • PTCT TTM cash from operations is now at all-time high.

Performance

PTCT TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTCTcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PTCT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+32.0%+13.9%+502.0%
3Y3 Years+57.1%-74.3%+375.7%
5Y5 Years-9.2%-348.7%+611.4%

PTCT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+69.8%-107.6%+60.0%at high+300.6%
5Y5-Year-9.2%+69.8%-107.6%+60.0%at high+300.6%
All-TimeAll-Time-970.1%+69.8%-107.6%+60.0%at high+300.6%

PTCT Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$66.30M(-13.7%)
$715.47M(+1.5%)
Jun 2025
-
-$58.33M(-106.7%)
$704.77M(+1.9%)
Mar 2025
-
$870.10M(+3000.0%)
$691.65M(+742.3%)
Dec 2024
-$107.69M(+32.0%)
-$30.00M(+61.0%)
-$107.69M(+39.5%)
Sep 2024
-
-$76.99M(-7.8%)
-$177.97M(-54.3%)
Jun 2024
-
-$71.45M(-201.0%)
-$115.37M(-98.3%)
Mar 2024
-
$70.76M(+170.6%)
-$58.17M(+63.3%)
Dec 2023
-$158.42M(+55.6%)
-$100.29M(-597.1%)
-$158.42M(+29.3%)
Sep 2023
-
-$14.39M(-0.9%)
-$224.09M(+9.5%)
Jun 2023
-
-$14.25M(+51.7%)
-$247.75M(+14.2%)
Mar 2023
-
-$29.49M(+82.2%)
-$288.74M(+19.0%)
Dec 2022
-$356.65M(-41.9%)
-$165.96M(-336.2%)
-$356.65M(-37.4%)
Sep 2022
-
-$38.05M(+31.1%)
-$259.53M(+4.8%)
Jun 2022
-
-$55.24M(+43.3%)
-$272.68M(-9.7%)
Mar 2022
-
-$97.40M(-41.5%)
-$248.58M(+1.1%)
Dec 2021
-$251.33M(-29.5%)
-$68.84M(-34.5%)
-$251.33M(-1.8%)
Sep 2021
-
-$51.19M(-64.4%)
-$246.86M(-46.1%)
Jun 2021
-
-$31.14M(+68.9%)
-$169.01M(+20.5%)
Mar 2021
-
-$100.16M(-55.6%)
-$212.67M(-9.6%)
Dec 2020
-$194.07M(-96.7%)
-$64.37M(-341.4%)
-$194.07M(-38.7%)
Sep 2020
-
$26.66M(+135.6%)
-$139.91M(+23.2%)
Jun 2020
-
-$74.81M(+8.3%)
-$182.07M(-25.7%)
Mar 2020
-
-$81.55M(-699.1%)
-$144.84M(-46.8%)
Dec 2019
-$98.64M(-256.9%)
-$10.21M(+34.2%)
-$98.64M(+4.8%)
Sep 2019
-
-$15.50M(+58.8%)
-$103.58M(-22.3%)
Jun 2019
-
-$37.58M(-6.3%)
-$84.70M(-79.8%)
Mar 2019
-
-$35.35M(-133.4%)
-$47.11M(-70.4%)
DateAnnualQuarterlyTTM
Dec 2018
-$27.64M(-174.7%)
-$15.14M(-548.4%)
-$27.64M(-414.5%)
Sep 2018
-
$3.38M(>+9900.0%)
$8.79M(+184.9%)
Jun 2018
-
$3000.00(+100.0%)
-$10.36M(-449.7%)
Mar 2018
-
-$15.88M(-174.6%)
$2.96M(+129.4%)
Dec 2017
-$10.06M(+90.3%)
$21.29M(+235.0%)
-$10.06M(+77.5%)
Sep 2017
-
-$15.77M(-218.4%)
-$44.67M(+15.7%)
Jun 2017
-
$13.32M(+146.1%)
-$52.98M(+41.7%)
Mar 2017
-
-$28.90M(-117.0%)
-$90.88M(+12.2%)
Dec 2016
-$103.57M(+16.7%)
-$13.32M(+44.7%)
-$103.57M(+14.1%)
Sep 2016
-
-$24.07M(+2.1%)
-$120.58M(+3.0%)
Jun 2016
-
-$24.59M(+40.9%)
-$124.27M(+4.0%)
Mar 2016
-
-$41.59M(-37.1%)
-$129.50M(-4.2%)
Dec 2015
-$124.34M(-117.1%)
-$30.33M(-9.3%)
-$124.34M(-21.9%)
Sep 2015
-
-$27.76M(+6.9%)
-$102.00M(-11.8%)
Jun 2015
-
-$29.82M(+18.1%)
-$91.27M(-13.7%)
Mar 2015
-
-$36.42M(-355.7%)
-$80.26M(-40.1%)
Dec 2014
-$57.27M(-22.1%)
-$7.99M(+53.1%)
-$57.27M(+10.2%)
Sep 2014
-
-$17.04M(+9.4%)
-$63.74M(-22.9%)
Jun 2014
-
-$18.81M(-40.0%)
-$51.88M(+1.2%)
Mar 2014
-
-$13.44M(+7.1%)
-$52.51M(-11.9%)
Dec 2013
-$46.92M(+2.1%)
-$14.46M(-179.4%)
-$46.92M(-44.6%)
Sep 2013
-
-$5.18M(+73.4%)
-$32.46M(-19.0%)
Jun 2013
-
-$19.43M(-147.7%)
-$27.28M(-247.7%)
Mar 2013
-
-$7.85M(+52.7%)
-$7.85M(+52.7%)
Dec 2012
-$47.93M(-130.8%)
-
-
Mar 2012
-
-$16.58M
-$16.58M
Dec 2011
-$20.77M
-
-

FAQ

  • What is PTC Therapeutics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for PTC Therapeutics, Inc.?
  • What is PTC Therapeutics, Inc. annual cash from operations year-on-year change?
  • What is PTC Therapeutics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for PTC Therapeutics, Inc.?
  • What is PTC Therapeutics, Inc. quarterly cash from operations year-on-year change?
  • What is PTC Therapeutics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for PTC Therapeutics, Inc.?
  • What is PTC Therapeutics, Inc. TTM cash from operations year-on-year change?

What is PTC Therapeutics, Inc. annual cash from operations?

The current annual cash from operations of PTCT is -$107.69M

What is the all-time high annual cash from operations for PTC Therapeutics, Inc.?

PTC Therapeutics, Inc. all-time high annual cash from operations is -$10.06M

What is PTC Therapeutics, Inc. annual cash from operations year-on-year change?

Over the past year, PTCT annual cash from operations has changed by +$50.73M (+32.02%)

What is PTC Therapeutics, Inc. quarterly cash from operations?

The current quarterly cash from operations of PTCT is -$66.30M

What is the all-time high quarterly cash from operations for PTC Therapeutics, Inc.?

PTC Therapeutics, Inc. all-time high quarterly cash from operations is $870.10M

What is PTC Therapeutics, Inc. quarterly cash from operations year-on-year change?

Over the past year, PTCT quarterly cash from operations has changed by +$10.69M (+13.89%)

What is PTC Therapeutics, Inc. TTM cash from operations?

The current TTM cash from operations of PTCT is $715.47M

What is the all-time high TTM cash from operations for PTC Therapeutics, Inc.?

PTC Therapeutics, Inc. all-time high TTM cash from operations is $715.47M

What is PTC Therapeutics, Inc. TTM cash from operations year-on-year change?

Over the past year, PTCT TTM cash from operations has changed by +$893.44M (+502.01%)
On this page